Dr. Reddy's Labs Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Oct 27, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
DRL filed a 6-K, just a standard update, nothing new to see here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 27, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is routine and does not contain specific financial or operational updates beyond its classification and reporting status.
Why It Matters
This filing confirms Dr. Reddy's Laboratories Ltd. is adhering to its reporting obligations as a foreign private issuer with the SEC, which is standard for international companies trading on US exchanges.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material non-public information that would typically impact stock price or indicate significant risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer of the 6-K report
- 0001575872-25-000642 (accession_number) — Unique identifier for the filing
- 20251027 (date) — Date of filing
- Hyderabad, India (location) — Company's principal executive office location
FAQ
What type of company is Dr. Reddy's Laboratories Ltd. according to the filing?
Dr. Reddy's Laboratories Ltd. is classified as a foreign private issuer and operates in the Pharmaceutical Preparations industry (SIC code 2834).
What is the filing date of this Form 6-K?
The filing date is October 27, 2025.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-10-27 06:49:25
Filing Documents
- rdy0814_6k.htm (6-K) — 52KB
- rdy0814_ex99-1.htm (EX-99.1) — 23KB
- rdy0814_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0814_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-25-000642.txt ( ) — 102KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: October 25, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3